Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Newton

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Neuropharmacology|June 1, 1984
No evidence for histamine-mediated morphine analgesiaL B Hough, K L Su, R C Goldschmidt, et al.
Journal of Medical Genetics|December 1, 1992
A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counsellingD G Evans, S M Huson, D Donnai, et al.
Journal of Foot and Ankle Research|March 28, 2018
National profile of foot orthotic provision in the United Kingdom, part 2: podiatrist, orthotist and physiotherapy practicesC J Nester, A Graham, A Martinez-Santos, et al.
Journal of Medical Genetics|December 1, 1992
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severityD G Evans, S M Huson, D Donnai, et al.
European Journal of Human Genetics : EJHG|May 30, 2001
Multiple origins of the mtDNA 7472insC mutation associated with hearing loss and neurological dysfunctionT P Hutchin, N C Navarro-Coy, G Van Camp, et al.
European Journal of Heart Failure|May 28, 2025
Global heart failure epidemiology versus enrolment in pivotal trials: A formidable mismatchGuillaume Baudry, Guowei Li, Ruoting Wang, et al.
Oncology Nursing Forum|October 16, 2020
Relations of Mindfulness and Illness Acceptance With Psychosocial Functioning in Patients With Metastatic Breast Cancer and CaregiversKelly Chinh, Ekin Secinti, Shelley A Johns, et al.
Clinical Genetics|March 13, 2003
USH1C: a rare cause of USH1 in a non-Acadian population and a founder effect of the Acadian alleleX M Ouyang, J F Hejtmancik, S G Jacobson, et al.
Contemporary Clinical Trials|October 10, 2020
Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancerCatherine E Mosher, Ellen Krueger, Adam T Hirsh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2018
Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trialCatherine E Mosher, Ekin Secinti, Ruohong Li, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Neuropharmacology|June 1, 1984
No evidence for histamine-mediated morphine analgesiaL B Hough, K L Su, R C Goldschmidt, et al.
Journal of Medical Genetics|December 1, 1992
A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counsellingD G Evans, S M Huson, D Donnai, et al.
Journal of Foot and Ankle Research|March 28, 2018
National profile of foot orthotic provision in the United Kingdom, part 2: podiatrist, orthotist and physiotherapy practicesC J Nester, A Graham, A Martinez-Santos, et al.
Journal of Medical Genetics|December 1, 1992
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severityD G Evans, S M Huson, D Donnai, et al.
European Journal of Human Genetics : EJHG|May 30, 2001
Multiple origins of the mtDNA 7472insC mutation associated with hearing loss and neurological dysfunctionT P Hutchin, N C Navarro-Coy, G Van Camp, et al.
European Journal of Heart Failure|May 28, 2025
Global heart failure epidemiology versus enrolment in pivotal trials: A formidable mismatchGuillaume Baudry, Guowei Li, Ruoting Wang, et al.
Oncology Nursing Forum|October 16, 2020
Relations of Mindfulness and Illness Acceptance With Psychosocial Functioning in Patients With Metastatic Breast Cancer and CaregiversKelly Chinh, Ekin Secinti, Shelley A Johns, et al.
Clinical Genetics|March 13, 2003
USH1C: a rare cause of USH1 in a non-Acadian population and a founder effect of the Acadian alleleX M Ouyang, J F Hejtmancik, S G Jacobson, et al.
Contemporary Clinical Trials|October 10, 2020
Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancerCatherine E Mosher, Ellen Krueger, Adam T Hirsh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2018
Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trialCatherine E Mosher, Ekin Secinti, Ruohong Li, et al.
Pageof 4